A Feasibility Study to Collect Data in Patients With Haemophilia

Hemophilia Clinical Trial

Official title:

A Multi Centre Study With no Treatment, Designed to Gain Information About the Haemophilia Patient Population

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00798499
• Other study ID #: D0960M00006
• Status: Completed
• Phase: Phase 0
• First received: November 12, 2008
• Last updated: July 1, 2009
• Start date: December 2008
• Est. completion date: June 2009

Study information

• Verified date: July 2009
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: Sweden: Medical Products Agency
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to collect reference data in patients with haemophilia. The study will also collect and store blood samples for potential future exploratory research in the disease area.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: June 2009
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Provision of written informed consent

• Patients with haemophilia, all severities

• At least 18 years old.

Exclusion Criteria:

• No exclusion criteria

Study Design

Observational Model: Case-Only

Related Conditions & MeSH terms

• Hemophilia
• Hemophilia A

Intervention

Other:
• Laboratory variables
1 visit

Locations

Country	Name	City	State
Sweden	Research Site	Malmö
Sweden	Research Site	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Laboratory variables related to coagulation, SAEs in connection to blood sampling procedures will be collected, non-serious AEs will not be recorded		The variables will be measured at first visit.	No